665 related articles for article (PubMed ID: 18590118)
1. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
2. [Recurrence of gastropathies caused by intake of nonsteroidal anti-inflammatory drugs].
Karameev AE
Ter Arkh; 2003; 75(5):74-8. PubMed ID: 12847904
[TBL] [Abstract][Full Text] [Related]
3. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases].
Karateev AE; Nasonova VA; Murav'ev IuV
Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549
[TBL] [Abstract][Full Text] [Related]
4. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia].
Karataev AE; Konovalova NN; Litovshenko AA; Lomareva NI; Nemtsov BF; Raskina TA; Peshekhonova LK; Nasonov EL
Klin Med (Mosk); 2005; 83(5):33-8. PubMed ID: 15984580
[TBL] [Abstract][Full Text] [Related]
5. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
7. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
Laine L
Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of peptic ulcer in 4943 inpatients.
Talamini G; Tommasi M; Amadei V; Pajusco B; Fratucello A; Lechi A; Scroccaro G; Vantini I
J Clin Gastroenterol; 2008 Apr; 42(4):373-80. PubMed ID: 18277902
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
Karateev AE; Nasonov EL; Radenska-Lopovok SG
Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
[TBL] [Abstract][Full Text] [Related]
13. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
Laine L
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
Karateev AE; Murav'ev IuV; Radenska-Lopovok SG; Nasonova VA
Klin Med (Mosk); 2003; 81(8):37-41. PubMed ID: 14520944
[TBL] [Abstract][Full Text] [Related]
16. Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage.
Bellary SV; Isaacs PE; Lee FI
Am J Gastroenterol; 1991 Aug; 86(8):961-4. PubMed ID: 1858761
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drug gastropathy.
Laine L
Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
[TBL] [Abstract][Full Text] [Related]
18. [Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate].
Karateev AE; Uspenskiĭ IuP; Pakhomova IG; Nasonov EL
Ter Arkh; 2009; 81(6):62-7. PubMed ID: 19663196
[TBL] [Abstract][Full Text] [Related]
19. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
20. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
Koch M; Dezi A; Ferrario F; Capurso I
Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
